XML 149 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CURRENT ASSETS:      
Cash $ 1,369,586 $ 2,856,309 $ 285,400
Rent receivable 81,854 80,829 197,473
Receivable from sale of equity method investment, current portion 975,000  
Prepaid expense and other current assets 367,818 299,360 367,994
Total Current Assets 2,794,258 3,236,498 850,867
NON-CURRENT ASSETS:      
Operating lease right-of-use assets, net 113,253 4,709 128,250
Receivable from sale of equity method investment, noncurrent portion 675,000  
Property and equipment, net 10,660 12,912 38,083
Investment in real estate, net 6,980,551 7,022,721 7,191,404
Equity method investments, net 10,636,544 12,095,020
Other non-current assets 36,067 71,794 278,912
Total Non-current Assets 7,815,531 17,748,680 19,731,669
Total Assets 10,609,789 20,985,178 20,582,536
CURRENT LIABILITIES:      
Accrued professional fees 984,869 611,462 1,804,100
Accrued research and development fees 153,772 153,772 208,772
Accrued payroll liability and compensation 550,931 501,258 588,722
Accrued litigation settlement 373,450 373,450 450,000
Accrued liabilities and other payables 524,872 434,117 272,915
Operating lease obligation, current portion 67,547 10,709 129,396
Equity method investment payable   666,667
Derivative liability 223,052 127,545 24,796
Note payable, net 5,745,254 5,715,447
Convertible note payable, net 2,397,528 2,113,773 1,925,146
Total Current Liabilities 14,449,353 13,882,555 6,762,686
NON-CURRENT LIABILITIES:      
Operating lease obligation, noncurrent portion 51,706 4,855
Note payable, net - noncurrent portion   5,596,219
Total Non-current Liabilities 51,706 6,451,074
Total Liabilities 14,501,059 13,882,555 13,213,760
Commitments and Contingencies
EQUITY:      
Preferred stock
Common stock, $0.0001 par value; 100,000,000 shares authorized; 1,445,979 shares issued and 1,442,512 shares outstanding at December 31, 2024; 736,769 shares issued and 733,302 shares outstanding at December 31, 2023 166 145 74
Additional paid-in capital 74,673,916 72,023,525 67,886,082
Less: common stock held in treasury, at cost; 3,467 shares at December 31, 2024 and 2023 (522,500) (522,500) (522,500)
Accumulated deficit (90,155,236) (87,673,125) (79,769,731)
Statutory reserve 6,578 6,578 6,578
Accumulated other comprehensive loss (231,721) (232,000) (231,727)
Total Avalon GloboCare Corp. stockholders’ (deficit) equity (3,891,270) 7,102,623 7,368,776
Noncontrolling interest
Total (Deficit) Equity (3,891,270) 7,102,623 7,368,776
Total Liabilities and Equity 10,609,789 20,985,178 20,582,536
Series A Convertible Preferred Stock      
EQUITY:      
Preferred stock 9,000,000 9,000,000
Series B Convertible Preferred Stock      
EQUITY:      
Preferred stock 11,000,000 11,000,000
Series C Convertible Preferred Stock      
EQUITY:      
Preferred stock 3,500,000 3,500,000
Series D Convertible Preferred Stock      
EQUITY:      
Preferred stock 8,837,527  
Related Party      
CURRENT LIABILITIES:      
Accrued liabilities and other payables - related parties 100,000 732,916 206,458
Advance from pending sale of noncontrolling interest - related party $ 3,328,078 3,108,106 485,714
NON-CURRENT LIABILITIES:      
Loan payable - related party   $ 850,000